Spectroscopic imaging of D-2-hydroxyglutarate and other metabolites in pre-surgical patients with IDH-mutant lower-grade gliomas.
Adam W AutryMarisa LafontaineLlewellyn JalbertElizabeth PhillipsJoanna J PhillipsJavier Villanueva-MeyerMitchel S BergerSusan M ChangYan LiPublished in: Journal of neuro-oncology (2022)
In vivo 2HG detection can reasonably be achieved on clinical scanners and increased levels may signal adverse PFS.